39 related articles for article (PubMed ID: 19493919)
1. Testicular/paratesticular mesothelial tumours: Uncommon histopathologic entities in a very complex anatomical site.
Pagliuca F; Lucà S; De Sio M; Arcaniolo D; Facchini G; De Martino M; Esposito F; DE Vita F; Chieffi P; Franco R
Pathol Res Pract; 2024 Jan; 253():155069. PubMed ID: 38181581
[TBL] [Abstract][Full Text] [Related]
2. Asbestos exposure and malignant mesothelioma of the tunica vaginalis testis: a systematic review and the experience of the Apulia (southern Italy) mesothelioma register.
Vimercati L; Cavone D; Delfino MC; De Maria L; Caputi A; Ferri GM; Serio G
Environ Health; 2019 Aug; 18(1):78. PubMed ID: 31470859
[TBL] [Abstract][Full Text] [Related]
3. Paratesticular müllerian-type papillary serous tumor in a child.
Cohen MC; Shawis R; Evans C
Pediatr Dev Pathol; 2009; 12(4):297-300. PubMed ID: 19348511
[TBL] [Abstract][Full Text] [Related]
4. h-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary.
Comin CE; Saieva C; Messerini L
Am J Surg Pathol; 2007 Aug; 31(8):1139-48. PubMed ID: 17667535
[TBL] [Abstract][Full Text] [Related]
5. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum.
Attanoos RL; Webb R; Dojcinov SD; Gibbs AR
Histopathology; 2002 Mar; 40(3):237-44. PubMed ID: 11895489
[TBL] [Abstract][Full Text] [Related]
6. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
Su XY; Li GD; Liu WP; Xie B; Jiang YH
Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical profile of paratesticular serous papillary adenocarcinoma and tunica vaginalis facilitates distinction from malignant mesothelioma.
Anchala PR; Dhir R; Parwani AV; Zynger DL
Int J Surg Pathol; 2011 Oct; 19(5):692-8. PubMed ID: 19493919
[TBL] [Abstract][Full Text] [Related]
8. Selected other problematic testicular and paratesticular lesions: rete testis neoplasms and pseudotumors, mesothelial lesions and secondary tumors.
Amin MB
Mod Pathol; 2005 Feb; 18 Suppl 2():S131-45. PubMed ID: 15502808
[TBL] [Abstract][Full Text] [Related]
9. Malignant mesothelioma of the tunica vaginalis testis: diagnostic studies and differential diagnosis.
Chekol SS; Sun CC
Arch Pathol Lab Med; 2012 Jan; 136(1):113-7. PubMed ID: 22208496
[TBL] [Abstract][Full Text] [Related]
10. Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas.
Ordóñez NG
Am J Surg Pathol; 1998 Oct; 22(10):1203-14. PubMed ID: 9777982
[TBL] [Abstract][Full Text] [Related]
11. A new case of malignant mesothelioma of the tunica vaginalis testis. Immunohistochemistry in comparison with an adenomatoid tumor of the testis.
Moch H; Ohnacker H; Epper R; Gudat F; Mihatsch MJ
Pathol Res Pract; 1994 Apr; 190(4):400-4; discussion 404-8. PubMed ID: 8078810
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
